PubMed HealthSearch

PubMed · 1507167

Adaptive classifiers for dicentric chromosomes.

Abstract

Classification of dicentric chromosomes in a practical automatic screening system comprises three stages. The first generates plausible centromere candidates from each chromosome in an automatically segmented metaphase, and uses contextual knowledge to generate distributions of "probably true" and "probably false" centromeres, thus adapting to the conditions within a particular metaphase. The second stage classifier uses these distributions to re-classify the candidates as centromeres or non-centromeres. From this classification, likely dicentrics are found by counting centromeres; a third classifier attempts to reject false positives among the likely dicentric chromosomes, by comparing the feature values of the proposed centromeres of a chromosome and rejecting chromosomes for which these values do not satisfy certain similarity criteria. The second stage classifier may be a simple box classifier, or may use a variety of parametric Bayesian methods. The performance of these alternatives has been tested both on reference data sets comprising about 600 metaphases, and on larger data sets when embedded in a practical fully automatic dicentric pre-screening system. When operating parameters were such that a similar number of true positives were found by both classifiers, the Bayesian classifier produced about half as many false positive errors as the box classifier, with the final false positive rate being in the region of one candidate dicentric chromosome in every four cells.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Piper, J Sprey. 1992. Adaptive classifiers for dicentric chromosomes.. https://doi.org/10.1269/jrr.33.supplement_159

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.

Translocations involving c-myc and an Ig locus have been reported rarely in human multiple myeloma (MM). Using specific fluorescence in situ hybridization probes, we show complex karyotypic abnormalities of the c-myc or L-myc locus in 19 of 20 MM cell lines and approximately 50% of advanced primary MM tumors. These abnormalities include unusual and complex translocations and insertions that often juxtapose myc with an IgH or IgL locus. For two advanced primary MM tumors, some tumor cells contain a karyotypic abnormality of the c-myc locus, whereas other tumor cells do not, indicating that this karyotypic abnormality of c-myc occurs as a late event. All informative MM cell lines show monoallelic expression of c-myc. For Burkitt's lymphoma and mouse plasmacytoma tumors, balanced translocation that juxtaposes c-myc with one of the Ig loci is an early, invariant event that is mediated by B cell-specific DNA modification mechanisms. By contrast, for MM, dysregulation of c-myc apparently is caused principally by complex genomic rearrangements that occur during late stages of MM progression and do not involve B cell-specific DNA modification mechanisms.

Chromosome Aberrations

Atlas of genetics and cytogenetics in oncology and haematology, an interactive database.

The 'Atlas of Genetics and Cytogenetics in Oncology and Haematology' (http://www.infobiogen.fr/services/chromcancer ) is a database devoted to chromosome abnormalities in cancer, cancer-prone diseases and genes involved in cancer. Information presented in each page is concise and updated. This database is made for and by: cytogeneticists, molecular biologists, clinicians in oncology and in haematology, and pathologists, who are encouraged to contribute.

Chromosome Aberrations